entertainment -WSS

entertainment

author：focus 2025-10-02 11:08:22 - browse：24519

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Involuntary treatment for addiction doesn't work

hotspot

focus

WSS

Can CDC director Mandy Cohen drive consensus in Washington?

Congress likely to miss an opportunity to fix drug shortages issue

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

New menopause drug shows promise in relief for hot flashes

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Biotech reporter’s notebook: A sunnier mood at JPM 2024

hotspot

entertainment

focus

ChatGPT in medicine: STAT answers readers' burning questions

How I ended up pumping milk in a bathroom stall at JPM 2024

After affirmative action ruling, medical educators look to 'holistic review'

J&J expands global access to TB drug amid advocacy campaign

Apple is now the first public company to be valued at $3 trillion

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Medicare details structure of new drug price negotiation program

Global childhood vaccinations edge closer to pre

leisure time

The nurse manager staffing crisis is hurting patients

The SUPPORT Act is critical to fighting the opioid crisis

Involuntary treatment for addiction doesn't work

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

The nurse manager staffing crisis is hurting patients

Woman gored by Bison at Yellowstone

explore

hotspot

focus

Wikipedia